Curing Death
  Recent News |  Archives |  Tags |  About |  Newsletter |  Submit News |  Advertise With Us |  Subscribe to CuringDeath.com RSS Fee Subscribe
New Articles
Study helps identify beachgoers at increased risk of skin cancer 11/21/2008

3 esophageal, stomach cancer subtypes linked to smoking - 1 associated with alcohol use 11/21/2008

'Let the sunshine in' to protect your heart this winter 11/20/2008

Researchers find clue to stopping breast-cancer metastasis 11/20/2008

Breaking BubR1 mimics genetic shuffle seen in cancer cells 11/20/2008

Researchers identify toehold for HIV's assault on brain 11/18/2008

No protective effect on cancer from long-term vitamin E or vitamin C supplementation 11/18/2008

The relative risk of brain cancer 11/18/2008

Breakthrough in cell-type analysis offers new ways to study development and disease 11/18/2008

Novel 4-drug combination proves safe for lung cancer treatment 11/18/2008

Protein compels ovarian cancer cells to cannibalize themselves 11/17/2008

Tiny sacs released by brain tumor cells carry information that may guide treatment 11/17/2008

Proton therapy and concurrent chemotherapy may reduce bone marrow toxicity in advanced lung cancer 11/17/2008

Researchers develop a new way to study how breast cancer spreads 11/17/2008

Scientists find cell pathway driving a deadly sub-type of breast cancer 11/17/2008

Being an MRSA carrier increases risk of infection and death (7/5/2008)

Tags:
mrsa, bacteria

Patients harboring methicillin-resistant Staphylococcus aureus (MRSA) for long periods of time continue to be at increased risk of MRSA infection and death, according to a new study in the July 15 issue of Clinical Infectious Diseases, currently available online.

MRSA is an antibiotic-resistant bacterium that can cause a variety of serious infections. The bacterium most commonly colonizes the nostrils, although it can be found in other body sites. Most research has focused on people who are newly colonized by the bacteria and has found that they are at substantial risk of subsequent infections. The new study shows that the increased risk of infection continues, with almost a quarter of MRSA-colonized patients developing infections after a year or more has passed since the colonization was confirmed. The infections include pneumonia and bloodstream events, and some infections were linked to deaths.

"Since infection risk remains substantial among long-term carriers of MRSA, these patients should be targeted for interventions to reduce subsequent risk of infection along with patients who newly acquire MRSA," said author Susan Huang, MD, MPH.

The researchers built on their previous work in this area, which showed that one-third of new MRSA carriers in a large tertiary care medical center developed infections within the year following the first detection of colonization. But, as, Dr. Huang points out, "risks beyond the first year of carriage were largely unknown."

In this study, Dr. Huang and coauthor Rupak Datta, MPH, followed 281 patients who had been MRSA-positive for at least one year and some for more than four years. Of these, 23 percent developed an MRSA infection within the year-long duration of this study. Pneumonia was the most common infection. MRSA was identified as a contributor to the deaths of 14 of the patients.

In their paper, the authors suggest that the MRSA infection risk may be more closely tied to a hospitalization event than to the duration of carriage: "We submit that these high risks of MRSA infection among culture-positive prevalent carriers are not only preferentially detected because of hospitalization, but may in fact be incurred because of device related, wound related, and immunologic declines associated with a current illness."

"One explanation for this may be that patients who have surgical wounds or intravenous lines may allow MRSA a route of entry and invasion that would not otherwise exist," added Dr. Huang.

The authors caution that because this study was performed in a large tertiary care medical center, they may have studied a disproportionate number of critically ill patients who could be at a relatively higher risk for infection. The results may not be generalizable to all patient settings.

Dr. Huang is currently an assistant professor in the Division of Infectious Diseases at the University of California Irvine. She was an infectious diseases physician at Brigham and Women's Hospital and an assistant professor at Harvard Medical School at the time this study was conducted.

Note: This story has been adapted from a news release issued by the Infectious Diseases Society of America

Debt Consolidation - Credit Cards - Mobile Phones - Credit Counseling

Post Comments:

Search

  Archives |  Submit News |  Advertise With Us |  Contact Us |  Links
All contents © 2000 - 2009 Web Doodle, LLC. All rights reserved.
Web Doodle, LLC does not provide medical advice, diagnosis or treatment. Please read our disclaimer